Although researchers have tried utmost for many decays to produce AIDS vaccine,   they have not been successful yet. Most of produced vaccines are not actually usable in practice due to high complications. However, now the Canadian researchers have succeeded in development of HIV vaccine, with no side-effects.
As reported by the borderless medical site reporter, it is necessary to conduct required clinical trial   at several stages on the new HIV Vaccine. About five years are needed for completion of the said process and entrance of the said vaccine at consumption market.
Researchers emphasize that since the said vaccines will probably be used for treatment of patients in the next five years, therefore, confronting HIV/AIDS must still be focused on prevention using tested and real methods such as distribution of Condom, circumcising, prevention of transmission of HIV from mothers to neonates and presenting syringe exchange plans.
Every year 400-500 Million US Dollars are spent for research on HIV Vaccine. Most of the said cost is paid for basic researches.
In spite of all efforts made in this regard, specific shape of HIV has caused that finding the said vaccine will be difficult and expensive. Segregating HIV from other infectious diseases has caused that the said virus directly attacks white blood cells, which are responsible for body safety response and disables the said cells to control infection and to prevent infection with the said virus.
“Common” vaccines are based on a complete microorganism (virus or bacterium), which have been killed or inactivated. The said vaccines are not reliable for AIDS, which may lead to infection. Consequently, HIV trial vaccines contain certain parts of viruses, which make production of the said vaccine more sophisticated.
The base for production of the genetically modified vaccine is killed virus and it has entered at test stage.   
This new vaccine is called “-H001SAV”.
The said virus has caused death of 30,000,000 individuals all over the world. Presently, over 34,000,000 persons are infected with the said virus.
It should be noted that presently, respective medicines used for treatment of AIDS are chemical ones, which are used as anti-virus medicines. In more than 30% cases, a patient has to replace the said medicine with another one or to change its dosage due to complications of the said medicines.
Variety in kinds of HIV has made the case more complicated. Various types of HIV virus, identified all over the world, are prevalent. Presently, researchers don’t know whether this new type of vaccine may cover the case thoroughly or it may be used for a specific kind of Virus.
The most prevalent kinds of HIV are subspecies of A and C, which exist in different regions in Africa. However, most of current reactions are done on the said kind; they cover the entire genetic aspect of subspecies B, which are dominant in countries of high incomes.